ARTICLES LIST

Clear Search

Select the Article Source National Cancer Institute Office of Dietary Supplements National Institute on Aging Healthfinder.gov National Institute of Child Health and Human Development Centers for Disease Control and Prevention Administration for Children and Families National Institute of Environmental Health Sciences National Library of Medicine National Institute of Allergy and Infectious Diseases National Center for Complementary and Integrative Health National Institute of Neurological Disorders and Stroke NIH Senior Health National Institute of Arthritis and Musculoskeletal and Skin Diseases Health and Human Services National Institute of General Medical Sciences National Institute of Dental and Craniofacial Research National Human Genome Research Institute Food and Drug Administration Center for Tobacco Products Public Health and Medical Emergency Support for a Nation Prepared Office of Disease Prevention and Health Promotion, Healthy People National Institute on Drug Abuse National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases U S Food and Drug Administration National Institute on Deafness and Other Communication Disorders National Heart, Lung, and Blood Institute

Media ID	Source Name	Media Type	Language	Media Name	Media Description	Keywords	Keywords	Link to Article
1133	Centers for Disease Control and Prevention	Html	en	Sign up for our Features | CDC Features	CDC.gov feature articles are written by subject matter experts and health communicators, then edited to emphasize strong call-to-action messages and friendly, meaningful visuals.	Centers 0.332535 list Skip 0.734485 Cancer feeds 0.507166 RSS news reader… 0.98022 page options Skip 0.904751 navigation Skip 0.743702 automatic updates 0.490747	Prevention 0.33232 desktop 0.332148 Disease Control 0.489241 browser 0.332062 easy way 0.491751 information 0.332918	CLICK HERE
4644	Centers for Disease Control and Prevention	Html	en	Conjunctivitis: Treatment	The treatment for conjunctivitis depends on the cause.	allergic conjunctivitis 0.462265 Mild bacterial conjunctivitis 0.592515 certain eye drops 0.333095 cold compresses 0.242448 topical antihistamine 0.226509 artificial tears 0.237374 herpes simplex virus 0.335841 red eye 0.219923 viral conjunctivitis 0.786656 best treatment options 0.315822 antibiotic resistance 0.241121 prescription eye 0.221183 pink eye 0.243657 contact lenses 0.233761 eye drops 0.339716 Fam Physician. 0.231905 antibiotic treatment 0.243323	antiviral medication 0.235201 specific treatment 0.226374 Allergy medications 0.217802 Kankanala RR 0.223069 conjunctivitis 0.927172 medical care 0.240413 increased costs 0.220695 doctor 0.27236 Mauger T. Diagnosis 0.331173 eye doctor 0.237638 varicella-zoster virus 0.23693 animal dander 0.21784 healthcare provider 0.234481 bacterial conjunctivitis 0.606385 following cases 0.221657 primary care 0.215496 antibiotics 0.25329	CLICK HERE
5977	Centers for Disease Control and Prevention	Html	en	Propoxur - NIOSH Pocket Guide to Chemical Hazards	null	MPEG 0.378858 search 0.263099 PDF 0.261307 PPT 0.446092	DOC 0.368812 information 0.262482 different file formats 0.938484 page 0.276773	CLICK HERE
6835	Centers for Disease Control and Prevention	Html	en	Global Health - Dr. Frieden visits Kenya	In Kenya, the CDC is addressing the region's toughest health problems at their source, directly working with vulnerable families and communities in local hospitals, clinics, and laboratories.	CDC 0.860943 CDC staff in-country 0.737051 foreign countries 0.504232 Secretary 0.416234 Laboratory Training Program 0.590482 demographic status 0.500026 polio eradication program 0.631368 U.S. efforts 0.507961 technical support 0.494493 Human Services Kathleen 0.574685 Institute 0.416538 CDC Field Research 0.742024 CDC-affiliated staff 0.503964 epicenter 0.422002 FETP/FELTP website 0.503549 laboratory training 0.60351 field station 0.497222 Dr. Tom Frieden 0.76604 disease surveillance 0.492073 Scott Gration 0.513561 important contributions 0.490518 officers 0.417393 important milestone 0.495945	CDC staff 0.837726 CDC overseas platforms 0.731937 laboratory training programs 0.587926 strategies 0.417008 Director 0.418938 polio case 0.554838 KEMRI 0.449683 CDC staff collect 0.746551 w/ largest gathering 0.583937 people 0.416266 Kenya Medical Research 0.677329 India 0.458617 global health activities 0.619272 dynamic public health 0.599801 TP programs 0.510105 U.S. Ambassador 0.514785 Kenyan health officials 0.630129 Kisian 0.416621 Field Epidemiology 0.525074 preventable deaths 0.521142 Learn 0.416992 information 0.416316 visit 0.431013	CLICK HERE
8268	Centers for Disease Control and Prevention	Html	en	Vital Signs: Carbapenem-Resistant Enterobacteriaceae	Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.	Escherichia coli 0.466345 CRE HAI 0.631009 CRE emergence.* Patients 0.624794 CRE definitions 0.610392 U.S. acute-care hospitals 0.475282 Current CRE prevention 0.622305 Klebsiella species 0.517705 Enterobacteriaceae infections 0.471007 CRE burden 0.593277 Nosocomial Infection Surveillance 0.504013 surgical site infections 0.466075 substantial health-care exposures 0.508069 Klebsiella pneumoniae carbapenemase 0.47937 acute-care hospitals 0.684702 CRE 0.926293 Laboratory Standards Institute 0.465443 population-based CRE surveillance 0.716057 United States 0.620626 health-care–associated infections 0.468467 panresistant Klebsiella pneumoniae 0.468596 Emerging Infections Program 0.506065 CRE control efforts 0.616337 central-line–associated bloodstream infections 0.468343 EIP CRE surveillance 0.641391	Klebsiella oxytoca 0.471968 long-term acute-care hospitals 0.544472 National Healthcare Safety 0.482458 CRE episodes 0.628771 health-care settings 0.50975 CRE bloodstream infections 0.623659 health-care infections 0.468808 CRE gains 0.582108 CRE surveillance project 0.713855 CRE prevention strategies 0.663682 CRE incidence 0.593682 pan-resistant CRE 0.599614 short-stay acute-care hospitals 0.505885 gram-negative bacilli 0.50432 carbapenem resistance 0.468966 proportion CRE 0.610677 urinary tract infections 0.46381 health-care facilities 0.46571 CRE patients 0.643311 CRE culture-positive episodes 0.746417 Healthcare Safety Network 0.529321 past decade 0.488091 Klebsiella pneumoniae 0.525158 National Nosocomial Infection 0.487718	CLICK HERE
8688	Centers for Disease Control and Prevention	Html	en	Announcements: Amyotrophic Lateral Sclerosis ALS AwarenessMonth - May 2013	Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.	mmwrq@cdc.gov. 0.33695 online web portal 0.424766 ALS risk factors 0.667018 better understanding 0.318299 new research notification 0.408959 United States 0.44038 U.S. Government Printing 0.414134 original MMWR paper 0.405769 Lou Gehrig 0.329231 brief online surveys 0.423113 registry surveys 0.35149 Human Services 0.417771 epidemiologic studies 0.318686 assistive technology 0.336718 neurodegenerative disorder 0.330091 new clinical trials 0.411163 active surveillance activities 0.409052 U.S. Department 0.541255 MMWR HTML versions 0.408862 Medicaid Services 0.323859 MMWR readers 0.318936 Amyotrophic Lateral Sclerosis 0.43536 federal Agency 0.324956 electronic PDF version 0.399487	Les Turner Foundation 0.411567 subject line 0.335666 Additional information 0.321002 metropolitan areas 0.316493 various initiatives 0.314996 national databases 0.32989 Contact GPO 0.330606 registry enrollees 0.360303 Muscular Dystrophy Association 0.417301 main goals 0.324058 potential risk factors 0.627437 persons 0.360628 sufficient data 0.332212 ATSDR 0.391939 web portal 0.438907 original paper copy 0.403042 potential specimen 0.317413 National ALS Registry 0.995022 bioregistry feasibility study 0.411306 Veterans Affairs 0.315537 ALS Association 0.580196 Disease Registry 0.379319 Toxic Substances 0.317997	CLICK HERE
9037	Centers for Disease Control and Prevention	Html	en	Notes from the Field: Occupationally Acquired Salmonella I4,12:i:1,2 Infection in a Phlebotomist - Minnesota, January2013	Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.	mmwrq@cdc.gov. 0.738302 personal risk 0.715438 clinical cases 0.725059 identification band 0.719885 symptom onset 0.744216 Human Services 0.791619 Minnesota Department 0.733629 assistive technology 0.732861 infection prevention specialist 0.853116 MMWR HTML versions 0.804563 U.S. Department 0.787503 Kirk E. Smith 0.803645 phlebotomist 0.722315 electronic PDF version 0.794114 Salmonella transmission 0.771137 health-care workers 0.846983 personal protective equipment 0.803078 C. Patient 0.747978 Contact GPO 0.73223 infected patients 0.738217 Ginette Dobbins 0.726259 occupationally acquired infections 0.809478 commercial sources 0.709454 Illness onset dates 0.849916	Minnesota Dept 0.712812 frozen mice 0.720471 original paper copy 0.798196 Joni Scheftel 0.713791 hand-held sample tracking 0.81983 regular disinfection 0.714244 indistinguishable PFGE pattern 0.848002 multistate outbreak 0.728515 Mary J. Choi 0.969555 U.S. Government Printing 0.804667 original MMWR paper 0.801582 Minnesota resident 0.719593 indistinguishable pulsed-field gel 0.859507 frozen feeder mice 0.819715 MMWR readers 0.716385 MDH Public Health 0.860793 subject line 0.731709 typeset documents 0.713517 trade names 0.709511 temporal relationship 0.714829 occupationally acquired Salmonella 0.876924 risk factor 0.713516 Richard Danila 0.711802 occupational person-to-person contact 0.818416	CLICK HERE
9225	Centers for Disease Control and Prevention	Html	en	Japanese Encephalitis Surveillance and Immunization - Asiaand the Western Pacific, 2012	Persons using assistive technology might not be able to fully access information in this file. For assistance, please send e-mail to: mmwrq@cdc.gov.	limited JE virus 0.384675 JE virus infection 0.416332 je laboratory network 0.472324 JE disease burden 0.392449 JE surveillance 0.699199 JE vaccine 0.615196 JE case 0.456439 Western Pacific Region 0.213137 JE immunization programs 0.459832 JE prevention activities 0.389795 JE risk 0.380243 JE immunization program 0.595277 national immunization programs 0.203587 effective JE prevention 0.378277 Susan L. Hills 0.200043 World Health Organization 0.226498 JE surveillance programs 0.475501 je prevention 0.459887	JE case reporting 0.393241 sentinel surveillance 0.207298 countries 0.301468 JE virus transmission 0.975698 JE control 0.425094 surveillance case definition 0.22018 surveillance sites 0.208533 JE vaccination program 0.387209 public health problem 0.279711 case definition 0.253208 government surveillance programs 0.216907 virus transmission risk 0.493745 risk areas 0.200388 JE vaccination 0.400127 laboratory confirmation 0.207494 JE cases 0.482208 pediatric JE vaccines 0.447179 Western Pacific 0.241774	CLICK HERE
14363	Centers for Disease Control and Prevention	Html	en	Tobacco Use Among Middle and High School Students - UnitedStates, 2011-2015 | MMWR	The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC).	current tobacco 0.278894 overall tobacco product 0.243191 Youth Tobacco Surveys 0.234609 electronic cigarettes 0.303768 Tobacco prevention 0.2096 tobacco control outcome 0.232916 tobacco product constituents 0.243672 conventional tobacco products 0.241954 tobacco 0.985462 dissolvable tobacco 0.273311 current tobacco product 0.252738 tobacco product types 0.244873 tobacco pipes 0.202683 tobacco product 0.836433 hookah tobacco 0.207933 middle school students 0.413912 comprehensive tobacco control 0.34538	cigars 0.281741 tobacco product prices 0.233709 certain tobacco products 0.259352 school current tobacco 0.244035 hookahs 0.229507 used tobacco product 0.238552 high school students 0.802307 tobacco pipe 0.208321 e-cigarettes 0.299378 tobacco control policies 0.262442 tobacco products 0.572382 smokeless tobacco 0.680322 single tobacco product 0.226304 commonly used tobacco 0.369991 pipe tobacco 0.563999 cigarettes 0.372179	CLICK HERE
15438	Centers for Disease Control and Prevention	Html	en	Evaluation of the Impact of National HIV Testing Day -United States, 2011-2014 | MMWR	The Morbidity and Mortality Weekly Report (MMWR) Series is prepared by the Centers for Disease Control and Prevention (CDC).	transgender persons 0.262883 CDC-funded HIV testing 0.544156 National HIV/AIDS Strategy 0.368578 HIV testing event 0.44739 single testing event 0.278512 NHTD 0.440903 number 0.389754 single conventional test 0.295624 HIV infections 0.686895 testing event data 0.278872 new HIV diagnoses 0.434453 individual HIV status 0.385121 mass testing campaigns 0.269652 HIV status 0.541431 new HIV diagnosis 0.393337 new HIV-positive test 0.292037 HIV testing campaigns 0.4352 new hiv-positive diagnoses 0.546229 racial/ethnic groups 0.279763 national testing event 0.278523 community-based testing events 0.277038 public health practice 0.264293 highest risk 0.292448 National HIV Prevention 0.417219 total testing events 0.280687	human immunodeficiency virus 0.424037 HIV test technology 0.407125 CDC-funded HIV tests 0.387515 CDC-funded testing events 0.290754 new hiv infections 0.603405 HIV testing events 0.825814 newly identified HIV 0.553589 United States 0.298276 HIV-positive persons 0.363105 national hiv testing 0.505167 total HIV testing 0.413733 significant increase 0.259284 National human immunodeficiency 0.271734 HIV-positive testing event 0.303502 HIV diagnosis 0.408697 valid HIV testing 0.44929 HIV test result 0.404726 HIV positive persons 0.440229 MSM 0.268115 hiv testing 0.946508 NHTD campaigns 0.262485 HIV 0.971202 target populations 0.259144 mass testing events 0.276504	CLICK HERE